Aptose Biosciences (APTO)
(Delayed Data from NSDQ)
$0.67 USD
-0.03 (-4.41%)
Updated Jul 16, 2024 03:59 PM ET
After-Market: $0.68 +0.01 (1.19%) 7:24 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -0.73 |
Last EPS Surprise | 10.98% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.62 |
Next Year | NA |
EPS (TTM) | -6.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.64 | -2.62 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -0.58 | -0.64 | -2.62 | NA |
High Estimate | -0.58 | -0.64 | -2.62 | NA |
Low Estimate | -0.58 | -0.64 | -2.62 | NA |
Year ago EPS | -2.27 | -1.76 | -7.58 | -2.62 |
Year over Year Growth Est. | 74.45% | 63.64% | 65.44% | NA |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 1 | 1 | 1 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.64 | -2.62 | NA |
7 Days Ago | -0.59 | -0.65 | -2.68 | -3.11 |
30 Days Ago | -0.59 | -0.65 | -2.68 | -3.11 |
60 Days Ago | -0.77 | -0.81 | -3.31 | -3.11 |
90 Days Ago | -0.77 | -0.81 | -3.31 | -3.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.58 | -0.64 | -2.62 | NA |
Zacks Consensus Estimate | -0.58 | -0.64 | -2.62 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.73 | -1.44 | -1.76 | -2.27 | NA |
Estimate | -0.82 | -1.48 | -2.16 | -2.09 | NA |
Difference | 0.09 | 0.04 | 0.40 | -0.18 | 0.09 |
Surprise | 10.98% | 2.70% | 18.52% | -8.61% | 5.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more